Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation

AIM: To determine the efficacy and toxicities of sorafenib in the treatment of patients with multiple recurrences of hepatocellular carcinoma (HCC) after liver transplantation in a Chinese population. METHODS: Twenty patients with multiple recurrences of HCC after liver transplantation were retrospe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tan, Wei-feng, Qiu, Zhi-quan, Yu, Yong, Ran, Rong-zheng, Yi, Bing, Lau, Wan-yee, Liu, Chen, Qiu, Ying-he, Feng, Fei-ling, Wang, Jing-han, Yan, Pei-ning, Zhang, Bai-he, Wu, Meng-chao, Luo, Xiang-ji, Jiang, Xiao-qing
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4002938/
https://ncbi.nlm.nih.gov/pubmed/21102481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2010.124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados